Skip to main content

NEOGEN CORP (NEOG) Stock Forecast 2025 - AI Price Prediction & Analysis


NEOGEN CORP (NEOG) AI Stock Price Forecast & Investment Analysis

NEOGEN CORP Stock Price Chart and Technical Analysis

Loading NEOGEN CORP interactive price chart and technical analysis...

NEOGEN CORP (NEOG) - Comprehensive Stock Analysis & Investment Research

Company Overview & Business Profile

NEOGEN CORP (Stock Symbol: NEOG) is a leading company in the Life Sciences sector , specifically operating within the In Vitro & In Vivo Diagnostic Substances industry. The organization employs approximately 1571 professionals worldwide . The company has established itself as an emerging investment opportunity with substantial growth potential.

Financial Performance & Key Metrics Analysis

Annual Revenue: $1107 million generating a -0.9% net profit margin .

Market Capitalization: $1211 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): 5.8% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Advanced AI Stock Prediction & Price Target Analysis

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for NEOGEN CORP stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Market Position & Competitive Advantage Analysis

NEOGEN CORP strategically competes in the highly dynamic In Vitro & In Vivo Diagnostic Substances marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities . The company demonstrates robust operational efficiency through strong free cash flow generation of $50 million annually , complemented by impressive -5.6% year-over-year cash flow growth. The company maintains a healthy 41.9% gross margin, indicating strong pricing power and operational efficiency.

NEOGEN CORP (NEOG) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for NEOGEN CORP stock analysis.

Loading NEOGEN CORP comprehensive fundamental analysis and insider trading data...

Deep dive into NEOGEN CORP's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if NEOGEN CORP stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For NEOGEN CORP: With a P/E ratio of -145.74, the market sees the stock as potentially undervalued.

P/E Ratio -145.74x
P/B Ratio 0.46x
Market Cap $1211M
EPS $-0.11
Book Value/Share $12.26
Revenue/Share $0.44
FCF/Share $0.54
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently NEOGEN CORP converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For NEOGEN CORP: An ROE of 5.8% indicates room for improvement in shareholder value creation.

ROE 5.8%
ROA 5.3%
ROIC 5.8%
Gross Margin 41.9%
Operating Margin 5.3%
Net Margin -0.9%
EBT Margin 11.9%
Tax Rate 20.1%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess NEOGEN CORP's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For NEOGEN CORP: A current ratio of 9.28 indicates strong liquidity.

Current Ratio 9.28x
Quick Ratio 7.17x
Financial Leverage 1.12x
Working Capital $538M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal NEOGEN CORP's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For NEOGEN CORP: Free cash flow of $50M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $70M
Free Cash Flow $50M
Capital Spending $-19M
OCF Growth YoY -5.6%
FCF Growth YoY -12.1%
FCF/Sales 9.8%
CapEx/Sales 3.7%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively NEOGEN CORP uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For NEOGEN CORP: An asset turnover of 0.55x suggests room for improvement in asset utilization.

Asset Turnover 0.55x
Receivables Turnover 5.7x
Inventory Turnover 2.6x
Fixed Assets Turnover 5.0x
Days Sales Outstanding 64 days
Days Inventory 139 days
Payables Period 31 days
Cash Conversion Cycle 173 days
Understanding Financial Statement Data

What these metrics mean: Key figures from NEOGEN CORP's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For NEOGEN CORP: With annual revenue of $1107M, NEOGEN CORP operates at significant scale.

Income Statement ($ Millions)
Total Revenue $1107M
Operating Income $41M
Net Income $-23M
R&D Expense $21M
SG&A Expense $31M
Cost of Goods Sold $460M
Balance Sheet Highlights ($ Millions)
Total Current Assets $62M
Cash & Short-term Investments $39M
Total Liabilities $11M
Accounts Receivable $9M
Inventory $12M
Dividend & Shareholder Information
Shares Outstanding 217M
Growth Metrics (YoY)
EPS Growth -0.9%

Latest NEOGEN CORP Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting NEOGEN CORP (NEOG) stock price and investment outlook.

📰 We are currently updating our news feed for NEOGEN CORP. Check back soon for the latest market analysis and company updates.

NEOGEN CORP Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of NEOGEN CORP against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Frequently Asked Questions - NEOGEN CORP Stock Forecast

How accurate are NEOGEN CORP stock predictions?

Our AI model demonstrates 47% historical accuracy for NEOG predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence NEOGEN CORP stock price forecasts?

Our analysis considers NEOGEN CORP's financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is NEOGEN CORP a good investment in 2025?

Based on our AI analysis, NEOGEN CORP shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are NEOGEN CORP forecasts updated?

NEOGEN CORP stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced NEOGEN CORP Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for NEOGEN CORP stock.

My Portfolio

Investment Dashboard

Loading your portfolio...